Featured Research

from universities, journals, and other organizations

Burst spinal artery aneurysm linked to Ecstasy use

Date:
July 4, 2014
Source:
BMJ-British Medical Journal
Summary:
Taking the street drug Ecstasy could lead to a potentially fatal weakening and rupture of the spinal cord artery, doctors warn. Posterior spinal artery aneurysms -- a blood-filled swelling of the spinal cord artery, caused by a weakening and distension of the vessel wall -- are rare, with only 12 cases reported to date. But all of them caused spinal bleeding which affected the function of the spinal cord. Doctors discovered one of these aneurysms in a previously healthy teenager who had taken Ecstasy or MDMA.

Taking the street drug Ecstasy could lead to a potentially fatal weakening and rupture of the spinal cord artery, doctors have warned in the Journal of NeuroInterventional Surgery.

Posterior spinal artery aneurysms -- a blood-filled swelling of the spinal cord artery, caused by a weakening and distension of the vessel wall -- are rare, with only 12 cases reported to date. But all of them caused spinal bleeding which affected the function of the spinal cord.

Doctors discovered one of these aneurysms in a previously healthy teenager who had taken Ecstasy or MDMA.

The morning after the night before, he woke up with headache, neck pain and muscle spasms. After a week these symptoms suddenly took a turn for the worse, accompanied by nausea, prompting him to seek help at his local emergency department.

A week later the teen was transferred to a specialist neurosurgical unit for further investigations, which revealed an aneurysm, measuring 2 x 1 mm, on the left side of the spinal cord artery at the back of his neck.

The aneurysm was successfully removed, along with the weakened portion of the artery. The teen made a full recovery, with no lasting nerve damage.

But the authors reiterate that Ecstasy use has already been linked to severe systemic and neurological complications, including stroke, inflammation of the arteries in the brain (vasculitis) and internal brain bleeds.

And now, posterior spinal artery aneurysm can be added to the list, they say.

The drug acts on the sympathetic nervous system, sparking a sudden hike in blood pressure, as a result of the surge in serotonin it releases. And this could make any pre-existing aneurysms or other arterial abnormalities prone to rupture, they warn.


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Johnson, S. Patel, E. Saraf-Lavi, M. A. Aziz-Sultan, D. R. Yavagal. Posterior spinal artery aneurysm rupture after 'Ecstasy' abuse. Case Reports, 2014; 2014 (jul02 2): bcr2014011248 DOI: 10.1136/bcr-2014-011248

Cite This Page:

BMJ-British Medical Journal. "Burst spinal artery aneurysm linked to Ecstasy use." ScienceDaily. ScienceDaily, 4 July 2014. <www.sciencedaily.com/releases/2014/07/140704134810.htm>.
BMJ-British Medical Journal. (2014, July 4). Burst spinal artery aneurysm linked to Ecstasy use. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/07/140704134810.htm
BMJ-British Medical Journal. "Burst spinal artery aneurysm linked to Ecstasy use." ScienceDaily. www.sciencedaily.com/releases/2014/07/140704134810.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins